[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global P2X7 Receptor Antagonists Market Growth (Status and Outlook) 2024-2030

May 2024 | 82 pages | ID: G1941678AE2EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.

The global P2X7 Receptor Antagonists market size is projected to grow from US$ 66.6 million in 2024 to US$ 123 million in 2030; it is expected to grow at a CAGR of 10.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “P2X7 Receptor Antagonists Industry Forecast” looks at past sales and reviews total world P2X7 Receptor Antagonists sales in 2022, providing a comprehensive analysis by region and market sector of projected P2X7 Receptor Antagonists sales for 2023 through 2029. With P2X7 Receptor Antagonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world P2X7 Receptor Antagonists industry.

This Insight Report provides a comprehensive analysis of the global P2X7 Receptor Antagonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on P2X7 Receptor Antagonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global P2X7 Receptor Antagonists market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for P2X7 Receptor Antagonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global P2X7 Receptor Antagonists.

United States market for P2X7 Receptor Antagonists is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for P2X7 Receptor Antagonists is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for P2X7 Receptor Antagonists is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key P2X7 Receptor Antagonists players cover GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of P2X7 Receptor Antagonists market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • GSK1482160
  • AZD9056
  • EVT 401
  • JNJ 55308942 & JNJ 54175446
  • AKP-23494954/RQ-00466479
  • Others
Segmentation by Application:
  • Inflammatory Diseases
  • Central Nervous System Diseases
  • Immune System Disorders
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Segmentation by Type:
  • GSK1482160
  • AZD9056
  • EVT 401
  • JNJ 55308942 & JNJ 54175446
  • AKP-23494954/RQ-00466479
  • Others
Segmentation by Application:
  • Inflammatory Diseases
  • Central Nervous System Diseases
  • Immune System Disorders
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GlaxoSmithKline
  • AstraZeneca
  • Janssen
  • RaQualia Pharma
  • Evotec
  • Asahi Kasei Pharma
  • Pfizer
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global P2X7 Receptor Antagonists Market Size 2019-2030
  2.1.2 P2X7 Receptor Antagonists Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for P2X7 Receptor Antagonists by Country/Region, 2019, 2023 & 2030
2.2 P2X7 Receptor Antagonists Segment by Type
  2.2.1 GSK1482160
  2.2.2 AZD9056
  2.2.3 EVT
  2.2.4 JNJ 55308942 & JNJ 54175446
  2.2.5 AKP-23494954/RQ-00466479
  2.2.6 Others
2.3 P2X7 Receptor Antagonists Market Size by Type
  2.3.1 P2X7 Receptor Antagonists Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
2.4 P2X7 Receptor Antagonists Segment by Application
  2.4.1 Inflammatory Diseases
  2.4.2 Central Nervous System Diseases
  2.4.3 Immune System Disorders
2.5 P2X7 Receptor Antagonists Market Size by Application
  2.5.1 P2X7 Receptor Antagonists Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)

3 P2X7 RECEPTOR ANTAGONISTS MARKET SIZE BY PLAYER

3.1 P2X7 Receptor Antagonists Market Size Market Share by Player
  3.1.1 Global P2X7 Receptor Antagonists Revenue by Player (2019-2024)
  3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by Player (2019-2024)
3.2 Global P2X7 Receptor Antagonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 P2X7 RECEPTOR ANTAGONISTS BY REGION

4.1 P2X7 Receptor Antagonists Market Size by Region (2019-2024)
4.2 Global P2X7 Receptor Antagonists Annual Revenue by Country/Region (2019-2024)
4.3 Americas P2X7 Receptor Antagonists Market Size Growth (2019-2024)
4.4 APAC P2X7 Receptor Antagonists Market Size Growth (2019-2024)
4.5 Europe P2X7 Receptor Antagonists Market Size Growth (2019-2024)
4.6 Middle East & Africa P2X7 Receptor Antagonists Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas P2X7 Receptor Antagonists Market Size by Country (2019-2024)
5.2 Americas P2X7 Receptor Antagonists Market Size by Type (2019-2024)
5.3 Americas P2X7 Receptor Antagonists Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC P2X7 Receptor Antagonists Market Size by Region (2019-2024)
6.2 APAC P2X7 Receptor Antagonists Market Size by Type (2019-2024)
6.3 APAC P2X7 Receptor Antagonists Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024)
7.2 Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024)
7.3 Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa P2X7 Receptor Antagonists by Region (2019-2024)
8.2 Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2019-2024)
8.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL P2X7 RECEPTOR ANTAGONISTS MARKET FORECAST

10.1 Global P2X7 Receptor Antagonists Forecast by Region (2025-2030)
  10.1.1 Global P2X7 Receptor Antagonists Forecast by Region (2025-2030)
  10.1.2 Americas P2X7 Receptor Antagonists Forecast
  10.1.3 APAC P2X7 Receptor Antagonists Forecast
  10.1.4 Europe P2X7 Receptor Antagonists Forecast
  10.1.5 Middle East & Africa P2X7 Receptor Antagonists Forecast
10.2 Americas P2X7 Receptor Antagonists Forecast by Country (2025-2030)
  10.2.1 United States Market P2X7 Receptor Antagonists Forecast
  10.2.2 Canada Market P2X7 Receptor Antagonists Forecast
  10.2.3 Mexico Market P2X7 Receptor Antagonists Forecast
  10.2.4 Brazil Market P2X7 Receptor Antagonists Forecast
10.3 APAC P2X7 Receptor Antagonists Forecast by Region (2025-2030)
  10.3.1 China P2X7 Receptor Antagonists Market Forecast
  10.3.2 Japan Market P2X7 Receptor Antagonists Forecast
  10.3.3 Korea Market P2X7 Receptor Antagonists Forecast
  10.3.4 Southeast Asia Market P2X7 Receptor Antagonists Forecast
  10.3.5 India Market P2X7 Receptor Antagonists Forecast
  10.3.6 Australia Market P2X7 Receptor Antagonists Forecast
10.4 Europe P2X7 Receptor Antagonists Forecast by Country (2025-2030)
  10.4.1 Germany Market P2X7 Receptor Antagonists Forecast
  10.4.2 France Market P2X7 Receptor Antagonists Forecast
  10.4.3 UK Market P2X7 Receptor Antagonists Forecast
  10.4.4 Italy Market P2X7 Receptor Antagonists Forecast
  10.4.5 Russia Market P2X7 Receptor Antagonists Forecast
10.5 Middle East & Africa P2X7 Receptor Antagonists Forecast by Region (2025-2030)
  10.5.1 Egypt Market P2X7 Receptor Antagonists Forecast
  10.5.2 South Africa Market P2X7 Receptor Antagonists Forecast
  10.5.3 Israel Market P2X7 Receptor Antagonists Forecast
  10.5.4 Turkey Market P2X7 Receptor Antagonists Forecast
10.6 Global P2X7 Receptor Antagonists Forecast by Type (2025-2030)
10.7 Global P2X7 Receptor Antagonists Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market P2X7 Receptor Antagonists Forecast

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline P2X7 Receptor Antagonists Product Offered
  11.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca P2X7 Receptor Antagonists Product Offered
  11.2.3 AstraZeneca P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Janssen
  11.3.1 Janssen Company Information
  11.3.2 Janssen P2X7 Receptor Antagonists Product Offered
  11.3.3 Janssen P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Janssen Main Business Overview
  11.3.5 Janssen Latest Developments
11.4 RaQualia Pharma
  11.4.1 RaQualia Pharma Company Information
  11.4.2 RaQualia Pharma P2X7 Receptor Antagonists Product Offered
  11.4.3 RaQualia Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 RaQualia Pharma Main Business Overview
  11.4.5 RaQualia Pharma Latest Developments
11.5 Evotec
  11.5.1 Evotec Company Information
  11.5.2 Evotec P2X7 Receptor Antagonists Product Offered
  11.5.3 Evotec P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Evotec Main Business Overview
  11.5.5 Evotec Latest Developments
11.6 Asahi Kasei Pharma
  11.6.1 Asahi Kasei Pharma Company Information
  11.6.2 Asahi Kasei Pharma P2X7 Receptor Antagonists Product Offered
  11.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Asahi Kasei Pharma Main Business Overview
  11.6.5 Asahi Kasei Pharma Latest Developments
11.7 Pfizer
  11.7.1 Pfizer Company Information
  11.7.2 Pfizer P2X7 Receptor Antagonists Product Offered
  11.7.3 Pfizer P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Pfizer Main Business Overview
  11.7.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. P2X7 Receptor Antagonists Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. P2X7 Receptor Antagonists Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of GSK1482160
Table 4. Major Players of AZD9056
Table 5. Major Players of EVT
Table 6. Major Players of JNJ 55308942 & JNJ 54175446
Table 7. Major Players of AKP-23494954/RQ-00466479
Table 8. Major Players of Others
Table 9. P2X7 Receptor Antagonists Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global P2X7 Receptor Antagonists Market Size by Type (2019-2024) & ($ millions)
Table 11. Global P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
Table 12. P2X7 Receptor Antagonists Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 13. Global P2X7 Receptor Antagonists Market Size by Application (2019-2024) & ($ millions)
Table 14. Global P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)
Table 15. Global P2X7 Receptor Antagonists Revenue by Player (2019-2024) & ($ millions)
Table 16. Global P2X7 Receptor Antagonists Revenue Market Share by Player (2019-2024)
Table 17. P2X7 Receptor Antagonists Key Players Head office and Products Offered
Table 18. P2X7 Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global P2X7 Receptor Antagonists Market Size by Region (2019-2024) & ($ millions)
Table 22. Global P2X7 Receptor Antagonists Market Size Market Share by Region (2019-2024)
Table 23. Global P2X7 Receptor Antagonists Revenue by Country/Region (2019-2024) & ($ millions)
Table 24. Global P2X7 Receptor Antagonists Revenue Market Share by Country/Region (2019-2024)
Table 25. Americas P2X7 Receptor Antagonists Market Size by Country (2019-2024) & ($ millions)
Table 26. Americas P2X7 Receptor Antagonists Market Size Market Share by Country (2019-2024)
Table 27. Americas P2X7 Receptor Antagonists Market Size by Type (2019-2024) & ($ millions)
Table 28. Americas P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
Table 29. Americas P2X7 Receptor Antagonists Market Size by Application (2019-2024) & ($ millions)
Table 30. Americas P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)
Table 31. APAC P2X7 Receptor Antagonists Market Size by Region (2019-2024) & ($ millions)
Table 32. APAC P2X7 Receptor Antagonists Market Size Market Share by Region (2019-2024)
Table 33. APAC P2X7 Receptor Antagonists Market Size by Type (2019-2024) & ($ millions)
Table 34. APAC P2X7 Receptor Antagonists Market Size by Application (2019-2024) & ($ millions)
Table 35. Europe P2X7 Receptor Antagonists Market Size by Country (2019-2024) & ($ millions)
Table 36. Europe P2X7 Receptor Antagonists Market Size Market Share by Country (2019-2024)
Table 37. Europe P2X7 Receptor Antagonists Market Size by Type (2019-2024) & ($ millions)
Table 38. Europe P2X7 Receptor Antagonists Market Size by Application (2019-2024) & ($ millions)
Table 39. Middle East & Africa P2X7 Receptor Antagonists Market Size by Region (2019-2024) & ($ millions)
Table 40. Middle East & Africa P2X7 Receptor Antagonists Market Size by Type (2019-2024) & ($ millions)
Table 41. Middle East & Africa P2X7 Receptor Antagonists Market Size by Application (2019-2024) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of P2X7 Receptor Antagonists
Table 43. Key Market Challenges & Risks of P2X7 Receptor Antagonists
Table 44. Key Industry Trends of P2X7 Receptor Antagonists
Table 45. Global P2X7 Receptor Antagonists Market Size Forecast by Region (2025-2030) & ($ millions)
Table 46. Global P2X7 Receptor Antagonists Market Size Market Share Forecast by Region (2025-2030)
Table 47. Global P2X7 Receptor Antagonists Market Size Forecast by Type (2025-2030) & ($ millions)
Table 48. Global P2X7 Receptor Antagonists Market Size Forecast by Application (2025-2030) & ($ millions)
Table 49. GlaxoSmithKline Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 50. GlaxoSmithKline P2X7 Receptor Antagonists Product Offered
Table 51. GlaxoSmithKline P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 52. GlaxoSmithKline Main Business
Table 53. GlaxoSmithKline Latest Developments
Table 54. AstraZeneca Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 55. AstraZeneca P2X7 Receptor Antagonists Product Offered
Table 56. AstraZeneca P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. AstraZeneca Main Business
Table 58. AstraZeneca Latest Developments
Table 59. Janssen Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 60. Janssen P2X7 Receptor Antagonists Product Offered
Table 61. Janssen P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Janssen Main Business
Table 63. Janssen Latest Developments
Table 64. RaQualia Pharma Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 65. RaQualia Pharma P2X7 Receptor Antagonists Product Offered
Table 66. RaQualia Pharma P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. RaQualia Pharma Main Business
Table 68. RaQualia Pharma Latest Developments
Table 69. Evotec Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 70. Evotec P2X7 Receptor Antagonists Product Offered
Table 71. Evotec P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Evotec Main Business
Table 73. Evotec Latest Developments
Table 74. Asahi Kasei Pharma Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 75. Asahi Kasei Pharma P2X7 Receptor Antagonists Product Offered
Table 76. Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Asahi Kasei Pharma Main Business
Table 78. Asahi Kasei Pharma Latest Developments
Table 79. Pfizer Details, Company Type, P2X7 Receptor Antagonists Area Served and Its Competitors
Table 80. Pfizer P2X7 Receptor Antagonists Product Offered
Table 81. Pfizer P2X7 Receptor Antagonists Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments

LIST OF FIGURES

Figure 1. P2X7 Receptor Antagonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global P2X7 Receptor Antagonists Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. P2X7 Receptor Antagonists Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. P2X7 Receptor Antagonists Sales Market Share by Country/Region (2023)
Figure 8. P2X7 Receptor Antagonists Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global P2X7 Receptor Antagonists Market Size Market Share by Type in 2023
Figure 10. P2X7 Receptor Antagonists in Inflammatory Diseases
Figure 11. Global P2X7 Receptor Antagonists Market: Inflammatory Diseases (2019-2024) & ($ millions)
Figure 12. P2X7 Receptor Antagonists in Central Nervous System Diseases
Figure 13. Global P2X7 Receptor Antagonists Market: Central Nervous System Diseases (2019-2024) & ($ millions)
Figure 14. P2X7 Receptor Antagonists in Immune System Disorders
Figure 15. Global P2X7 Receptor Antagonists Market: Immune System Disorders (2019-2024) & ($ millions)
Figure 16. Global P2X7 Receptor Antagonists Market Size Market Share by Application in 2023
Figure 17. Global P2X7 Receptor Antagonists Revenue Market Share by Player in 2023
Figure 18. Global P2X7 Receptor Antagonists Market Size Market Share by Region (2019-2024)
Figure 19. Americas P2X7 Receptor Antagonists Market Size 2019-2024 ($ millions)
Figure 20. APAC P2X7 Receptor Antagonists Market Size 2019-2024 ($ millions)
Figure 21. Europe P2X7 Receptor Antagonists Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa P2X7 Receptor Antagonists Market Size 2019-2024 ($ millions)
Figure 23. Americas P2X7 Receptor Antagonists Value Market Share by Country in 2023
Figure 24. United States P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC P2X7 Receptor Antagonists Market Size Market Share by Region in 2023
Figure 29. APAC P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
Figure 30. APAC P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)
Figure 31. China P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 35. India P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe P2X7 Receptor Antagonists Market Size Market Share by Country in 2023
Figure 38. Europe P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
Figure 39. Europe P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)
Figure 40. Germany P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 41. France P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 42. UK P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa P2X7 Receptor Antagonists Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa P2X7 Receptor Antagonists Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa P2X7 Receptor Antagonists Market Size Market Share by Application (2019-2024)
Figure 48. Egypt P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries P2X7 Receptor Antagonists Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 54. APAC P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 55. Europe P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 57. United States P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 58. Canada P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 59. Mexico P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 60. Brazil P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 61. China P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 62. Japan P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 63. Korea P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 65. India P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 66. Australia P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 67. Germany P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 68. France P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 69. UK P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 70. Italy P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 71. Russia P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 72. Egypt P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 73. South Africa P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 74. Israel P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 75. Turkey P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries P2X7 Receptor Antagonists Market Size 2025-2030 ($ millions)
Figure 77. Global P2X7 Receptor Antagonists Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global P2X7 Receptor Antagonists Market Size Market Share Forecast by Application (2025-2030)


More Publications